Collier Michael Manning sold 3,300 shares of HEALTHSTREAM INC at $30.60 for −$101k on Nov 5, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Executive Vice President
Executive Vice President
Filed Nov 6, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$100,970.76Shares × reported price
Shares traded
3,300Common Stock
Price per share
$30.60Reported price. Read footnotes for ranges.
% of reported position traded
5.27%This security and ownership context
Holdings after
59,260Direct
Trade date
Nov 5, 2026Sell
Filed
Nov 6, 2026, 4:30 PM ET1-day reporting delay
Accession
0001437749-26-035587Code S · Transaction 394888
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 62,560 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 5, 2026Option exercise18,000$20.34$366,120Trade 394889
Nov 5, 2026Option exercise18,000$0.00$0Trade 394891
Nov 5, 2026Sell18,000$29.85−$537,363Trade 394890
4 transaction rows in this filing. Joint filers share the same rows.

HSTM price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
HSTM · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +8.4%1w ago +17%1d ago +12%
Returns since7d −3.2%30d90d180d1y

Footnotes in full

F1: This transaction was executed in multiple trades at prices ranging from $30.23 to $31.01. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F2: The exercise and sale were effected through a broker-assisted cashless exercise. F3: This transaction was executed in multiple trades at prices ranging from $29.41 to $30.36. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F4: The options vested according to the following schedule: 15% vested on December 9, 2021, 20% vested on December 9, 2022, 30% vested on December 9, 2023, and the remaining 35% vested on December 9, 2024.